Agile Vaccine Development Expertise

Preventing and Treating Cancers and Infectious Diseases

Vaccine developers worldwide are faced with the challenge of quickly and safely advancing their vaccines through clinical development and approval to prevent millions of deaths every year.   Infectious disease pandemics like Ebola, MERS and COVID-19 come to mind currently, requiring a rapid response to a regional or global outbreak. Equally important are vaccines to prevent or treat cancers, viral, and bacterial infections that impact the length or quality of human lives.  

Understanding Vaccines

We understand that vaccine development has a unique set of challenges, so Veristat has assembled an extraordinary team of scientific-minded experts who have planned and executed over 140 vaccine clinical trials and supported 8 BLA marketing applications.  

Whether a vaccine to prevent or treat cancer recurrance or progression, or rapidly responding to an infectious disease outbreak, like the ongoing COVID-19 pandemic, we solve the problems that arise in testing immunotherapy vaccines, live or inactivated viral vaccines or DNA vaccines.


Breadth of Vaccine Experience

Veristat Cancer and Preventative Vaccine Indications

Learn More with These Resources

Case Study
Rapid Launch of a Phase I COVID-19 Vaccine Trial

Learn how the Veristat team quickly mobilized to help a sponsor get their clinical trial databased designed and launched in two weeks in order to achieve ...

Fact Sheet
COVID-19 Success Guide

As you consider the impact that the COVID-19 pandemic has on your programs, there are some key strategies that could help you maintain momentum, assess your risks and ...

Case Study
Rapid Response to Ebola Outbreak

When the WHO declared the Ebola Outbreak of 2014 in Africa a Global Health Emergency, Veristat was contacted to quickly set up clinical trial sites. Learn how we ...

Request A Proposal